[精确精神病学中免疫代谢轨迹的第一次成功]。

IF 0.4 4区医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL

M S-medecine Sciences Pub Date : 2025-05-01 Epub Date: 2025-05-26 DOI:10.1051/medsci/2025063

Ophélia Godin, Ariel Frajerman, Aiste Lengvenyte, Jeremy Bernard, Ana C Andreazza, Bruno Etain, Marion Leboyer

{"title":"[精确精神病学中免疫代谢轨迹的第一次成功]。","authors":"Ophélia Godin, Ariel Frajerman, Aiste Lengvenyte, Jeremy Bernard, Ana C Andreazza, Bruno Etain, Marion Leboyer","doi":"10.1051/medsci/2025063","DOIUrl":null,"url":null,"abstract":"Psychiatric disorders are associated with a high prevalence of cardiovascular and metabolic risk factors such as diabetes, obesity, and metabolic syndrome, as well as specific symptoms: hyperphagia, weight gain, hypersomnia, fatigue, and anhedonia. Non-pharmacological therapeutic strategies (exercise, Mediterranean or ketogenic diets) as well as pharmacological approaches, such as repositioning molecules (metformin or GLP1 receptor agonists), are available and could be proposed to these patients. In addition, targeting immuno-inflammatory pathways may be beneficial for these individuals.","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"41 5","pages":"490-499"},"PeriodicalIF":0.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The first successes of the immuno-metabolic track in precision psychiatry].\",\"authors\":\"Ophélia Godin, Ariel Frajerman, Aiste Lengvenyte, Jeremy Bernard, Ana C Andreazza, Bruno Etain, Marion Leboyer\",\"doi\":\"10.1051/medsci/2025063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Psychiatric disorders are associated with a high prevalence of cardiovascular and metabolic risk factors such as diabetes, obesity, and metabolic syndrome, as well as specific symptoms: hyperphagia, weight gain, hypersomnia, fatigue, and anhedonia. Non-pharmacological therapeutic strategies (exercise, Mediterranean or ketogenic diets) as well as pharmacological approaches, such as repositioning molecules (metformin or GLP1 receptor agonists), are available and could be proposed to these patients. In addition, targeting immuno-inflammatory pathways may be beneficial for these individuals.\",\"PeriodicalId\":18205,\"journal\":{\"name\":\"M S-medecine Sciences\",\"volume\":\"41 5\",\"pages\":\"490-499\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"M S-medecine Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1051/medsci/2025063\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"M S-medecine Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1051/medsci/2025063","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

摘要

精神疾病与心血管和代谢危险因素（如糖尿病、肥胖和代谢综合征）的高发率以及特定症状（如贪食、体重增加、嗜睡、疲劳和快感缺乏）有关。非药物治疗策略（运动，地中海或生酮饮食）以及药理学方法，如重新定位分子（二甲双胍或GLP1受体激动剂）是可用的，可以向这些患者提出。此外，靶向免疫炎症途径可能对这些个体有益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[The first successes of the immuno-metabolic track in precision psychiatry].

Psychiatric disorders are associated with a high prevalence of cardiovascular and metabolic risk factors such as diabetes, obesity, and metabolic syndrome, as well as specific symptoms: hyperphagia, weight gain, hypersomnia, fatigue, and anhedonia. Non-pharmacological therapeutic strategies (exercise, Mediterranean or ketogenic diets) as well as pharmacological approaches, such as repositioning molecules (metformin or GLP1 receptor agonists), are available and could be proposed to these patients. In addition, targeting immuno-inflammatory pathways may be beneficial for these individuals.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

M S-medecine Sciences 医学-医学：研究与实验

CiteScore

0.80

自引率

14.30%

发文量

182

审稿时长

4-8 weeks

期刊介绍： m/s offers high-quality review articles in French, covering all areas of biomedical and health research, in a monthly magazine format (10 issues / year). m/s is read by the whole French-speaking community, in France but also in Belgium, Switzerland, Canada, Morocco, Algeria, Tunisia etc. m/s is not a primary publication, and thus will not consider unpublished data. Most articles are invited by the Editors, but spontaneous proposals are welcomed. Each issue combines news and views on the most recent scientific publications, as well as broadly accessible and updated review articles on a specific topic, and essays on science and society, history of science, public health, or reactions to published articles. Each year, m/s also publishes one or two thematic issues focused on a research topic of high interest. All review articles and essays are peer-reviewed.